ALSF Childhood Cancer Research Grants
With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,500 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
Project Title |
Institution / Principal Investigator(s) | Grant Type | Year | State |
|---|---|---|---|---|
| Development of a childhood leukemia translational research program. | Dana-Farber Cancer Institute / Lewis Silverman | Phase I/II Infrastructure Grants | 2009 | Massachusetts |
| Development of a Childhood Leukemia Translational Research Program | Dana-Farber Cancer Institute / Lewis Silverman | Phase I/II Infrastructure Grants | 2011 | Massachusetts |
| Development and Characterization of Novel Models of Human Osteosarcoma Development and Metastasis | University of Minnesota / Beau Webber, PhD | Young Investigator Grants | 2017 | Minnesota |
| Developing Targeted Immunotherapy Against Pediatric Acute Myeloid Leukemia | Fred Hutchinson Cancer Research Center / Melinda Biernacki, MD | Young Investigator Grants | 2016 | Washington |
| Developing Personalized (precision) Medicine Strategies to Optimize Pediatric Brain Tumor Management | Washington University / David Gutmann, M.D., Ph.D. | Innovation Grants | 2014 | Missouri |
| Developing Novel Transcription Factor PROTACs to Disrupt the HMGA1 Epigenome in Relapsed Leukemia | Icahn School of Medicine at Mount Sinai / Linda Resar, MD and Jian Jin, PhD | Innovation Grants | 2022 | New York |
| Developing Novel Transcription Factor PROTACs to Disrupt the HMGA1 Epigenome in Relapsed Leukemia | The Johns Hopkins University School of Medicine / Linda Resar, MD and Jian Jin, PhD | Innovation Grants | 2022 | Maryland |
| Developing Immune-modulatory Strategies Against Primary and Metastatic Tumors in the Central Nervous System | Case Western Reserve University / Alex Huang, MD, PhD | Innovation Grants | 2012 | Ohio |
| Developing drugs to treat NT5C2 mediated resistance in pediatric ALL | New York University School of Medicine / William Carroll, MD | Innovation Grants | 2019 | New York |
| Developing and Distributing a Pediatric Spinal Cord High-grade Glioma Model | Stanford University / Michelle Monje, MD/PhD | Innovation Grants | 2016 | California |